Cargando…

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

BACKGROUND: Cardiac adipose tissue may have local paracrine effects on epicardial arteries and the underlying myocardium, promoting calcification and affecting myocardial microcirculation. We explored whether the total amount of cardiac adipose tissue was associated with coronary artery calcium scor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zobel, Emilie H., Christensen, Regitse Højgaard, Winther, Signe A., Hasbak, Philip, Hansen, Christian Stevns, von Scholten, Bernt J., Holmvang, Lene, Kjaer, Andreas, Rossing, Peter, Hansen, Tine W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011555/ https://www.ncbi.nlm.nih.gov/pubmed/32041610 http://dx.doi.org/10.1186/s12933-020-0995-x

Ejemplares similares

Myocardial flow reserve assessed by cardiac (82)Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetes
por: Zobel, Emilie H, et al.
Publicado: (2019)

Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
por: Rasmussen, Ida K. B., et al.
Publicado: (2021)

The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls
por: Laursen, Jens Christian, et al.
Publicado: (2021)

Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?
por: Christensen, Regitse Højgaard, et al.
Publicado: (2020)

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes
por: Christensen, Regitse H., et al.
Publicado: (2019)

Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R(+) T cells
por: von Scholten, Bernt Johan, et al.
Publicado: (2016)

Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
por: Zobel, Emilie H., et al.
Publicado: (2021)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatment
por: Zobel, Emilie H., et al.
Publicado: (2019)

The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials
por: Zobel, Emilie H., et al.
Publicado: (2021)

Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [(64)Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
por: Jensen, Jacob K., et al.
Publicado: (2021)

Effect of Liraglutide on Arterial Inflammation Assessed as [(18)F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Ripa, Rasmus S., et al.
Publicado: (2021)

Effect of Liraglutide on Vascular Inflammation Evaluated by [(64)Cu]DOTATATE
por: Zobel, Emilie H., et al.
Publicado: (2021)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
por: Zobel, Emilie H., et al.
Publicado: (2017)

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
por: Wretlind, Asger, et al.
Publicado: (2022)

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2015)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
por: Wretlind, Asger, et al.
Publicado: (2023)

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes
por: Stougaard, Elisabeth Buur, et al.
Publicado: (2021)

Neuroticism, depression and anxiety in takotsubo cardiomyopathy
por: Christensen, Thomas Emil, et al.
Publicado: (2016)

Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography
por: Lassen, Martin Lyngby, et al.
Publicado: (2023)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
por: Sivalingam, Suvanjaa, et al.
Publicado: (2021)

Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
por: Tougaard, Ninna Hahn, et al.
Publicado: (2020)

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes – An observational follow-up study
por: Frimodt-Møller, Marie, et al.
Publicado: (2018)

Effect of large weight reductions on measured and estimated kidney function
por: von Scholten, Bernt Johan, et al.
Publicado: (2017)

Vascular Inflammation as a Therapeutic Target in COVID-19 “Long Haulers”: HIITing the Spot?
por: Christensen, Regitse Højgaard, et al.
Publicado: (2021)

Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria
por: Poulsen, Christina Gjerlev, et al.
Publicado: (2023)

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients
por: Ghotbi, Adam Ali, et al.
Publicado: (2017)

Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2014)

Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes
por: Christensen, Marie Mathilde Bjerg, et al.
Publicado: (2020)

Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?
por: Hansen, Christian S., et al.
Publicado: (2023)

Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions
por: Eickhoff, Mie Klessen, et al.
Publicado: (2020)

Cardiac Microvascular Dysfunction in Women Living With HIV Is Associated With Cytomegalovirus Immunoglobulin G
por: Knudsen, Andreas, et al.
Publicado: (2018)

Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
por: Ferreira-Divino, Luis F., et al.
Publicado: (2022)

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice
por: von Scholten, Bernt Johan, et al.
Publicado: (2022)

NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients
por: Reinhard, Henrik, et al.
Publicado: (2012)

Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes
por: Lopes de Melo, Joana Mendes, et al.
Publicado: (2022)

Persons with type 1 diabetes have low blood oxygen levels in the supine and standing body positions
por: Laursen, Jens Christian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3l4qs5cjbid7thbv1ibal1vbk9